0000886163-18-000096.txt : 20180703
0000886163-18-000096.hdr.sgml : 20180703
20180703183926
ACCESSION NUMBER: 0000886163-18-000096
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180619
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAMATTINA JOHN L
CENTRAL INDEX KEY: 0001216074
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 18938921
MAIL ADDRESS:
STREET 1: 81 WYMAN ST
STREET 2: POST OFFICE BOX 9046
CITY: WALTHAM
STATE: MA
ZIP: 02454
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4/A
2018-06-19
2018-06-21
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001216074
LAMATTINA JOHN L
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
1
0
0
0
Non-Qualified Stock Option (right to buy)
195.91
2018-06-19
4
A
0
2474
0.0
A
2028-06-18
Common Stock
2474
2474
D
This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
By: Charles S. Berkman For: John L. LaMattina
2018-07-03